NCT00004012View on ClinicalTrials.gov

Capecitabine in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

December 31, 1998

Primary Completion Date

December 31, 2000

Study Completion Date

December 31, 2000

Conditions

Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer

Interventions

DRUG

capecitabine

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00004012 - Capecitabine in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | Biotech Hunter | Biotech Hunter